🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
Eisai
-5.62%
Pharma / Pharmaceuticals, Healthcare
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | Web1. Increasing pressure from generic drugmakers: Due to the growing popularity of generic drugs, Eisai Co. Ltd. may be faced with increased competition in the pharmaceutical market.
2. Aging population: The aging population in Japan and other countries is leading to an increase in demand for medicines to treat age-related illnesses. This could lead to higher costs and increased competition for Eisai Co. Ltd.
3. Changes in government regulations: Unpredictable changes in government regulations could adversely affect the commercial prospects of Eisai Co. Ltd.’s products.
4. Dependence on external suppliers: Eisai Co. Ltd. is heavily dependent on external suppliers for raw materials and other components needed for its products. This exposes the company to risks such as delays and price fluctuations.
5. Global economic volatility: Global economic volatility could have a negative impact on Eisai Co. Ltd.'s profits and bottom line.
Wait! There's more — sign up for free or log in